Search
Echinacoside
go.drugbank.com/drugs/DB15488InvestigationalEchinacoside is a phenylethanoid glycoside isolated from _Echinacea angustifolia_ in 1950, and currently being investigated for the treatment of Parkinson's, Alzheimer's, atherosclerosis, osteoporosis, … [A184577] Echinacoside has demonstrated inhibition of apoptosis in neural cell lines, demonstrating potential for use in the treatment of neurological conditions.[A184592]
Gefitinib
go.drugbank.com/drugs/DB00317ApprovedInvestigationalIt is marketed by AstraZeneca under the trade name Iressa.
Interferon alfa-2b
go.drugbank.com/drugs/DB00105ApprovedInvestigationalThis protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
SM-1997
go.drugbank.com/drugs/DB18670Experimental[A261816] It is under investigation for the treatment of cutaneous sulfur mustard-induced injury. … SM-1997 is a protein-free solution derived from calf's blood comprising electrolytes, trace minerals, amino acids, peptides, nucleosides, and nucleotides.
Arbekacin
go.drugbank.com/drugs/DB06696InvestigationalOften used for treatment of multi-resistant bacterial infection such as methicillin-resistant _Staphylococcus aureus_ (MRSA).
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseSpermine
go.drugbank.com/drugs/DB00127InvestigationalNutraceuticalSpermine is a spermidine-derived biogenic polyamine found as a polycation at all pH values. Found in various tissues and organisms, it often acts as an essential growth factor in some bacterial species. Spermine is associated with nuclei...
NM-702
go.drugbank.com/drugs/DB05505InvestigationalIn the USA, a Phase 2 study for intermittent claudication caused by arteriosclerosis obliterans has been successfully completed. … In Japan, Phase 2 studies are being conducted for intermittent claudication caused by arteriosclerosis obliterans, intermittent claudication caused by spinal canal stenosis, and asthma.